Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.

As columnist Colleen Steele sets her intentions for 2025, she promises the PH community that she will continue raising awareness.

People with pulmonary arterial hypertension (PAH) and their physicians hardly ever agree on the severity of symptoms, a study in the U.S., Europe and Japan reveals. Symptom discordance was more likely ...

Lung tissue and cells from the blood vessels that pass through the lungs derived from people with pulmonary arterial hypertension (PAH) produced fewer vitamin D receptors (VDRs) than normal, a study ...

I was diagnosed with pulmonary hypertension in 1999, when I was just 4 years old. My parents were obviously responsible for overseeing my healthcare at the time, particularly my mother, who has been ...

“God Rest Ye Merry, Gentlemen” is one of the oldest Christmas carols. The lyrics, which have been altered numerous times to adapt to changes within the English language, are drawn from the Christmas ...

An oxygen-sensing protein called hypoxia-inducible factor-1alpha, or HIF-1alpha, may contribute to worsening pulmonary arterial hypertension (PAH) and is a possible therapeutic target for people with ...

Using in-depth analyses and machine learning, scientists have identified several molecules and genes involved in metabolism that may be diagnostic markers of pulmonary arterial hypertension (PAH).

Blood levels of angiopoietin-2, a marker of blood vessel damage, may help predict treatment response and outcomes in pulmonary arterial hypertension (PAH), according to a new study from researchers in ...